| Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation F Garcia Soriano, L Virag, P Jagtap, E Szabo, JG Mabley, L Liaudet, ... Nature medicine 7 (1), 108-113, 2001 | 789 | 2001 |
| Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention L Virág, É Szabó, P Gergely, C Szabó Toxicology letters 140, 113-124, 2003 | 640 | 2003 |
| The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes P Pacher, L Liaudet, FG Soriano, JG Mabley, E Szabo, C Szabo Diabetes 51 (2), 514-521, 2002 | 371 | 2002 |
| Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction P Pacher, L Liaudet, P Bai, JG Mabley, PM Kaminski, L Virág, A Deb, ... Circulation 107 (6), 896-904, 2003 | 356 | 2003 |
| Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose) polymerase L Liaudet, FG Soriano, É Szabo, L Virág, JG Mabley, AL Salzman, ... Proceedings of the National academy of Sciences 97 (18), 10203-10208, 2000 | 259 | 2000 |
| Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents P Jagtap, FG Soriano, L Virág, L Liaudet, J Mabley, É Szabó, G Haskó, ... Critical care medicine 30 (5), 1071-1082, 2002 | 248 | 2002 |
| Poly (ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation G Szabó, S Bährle, N Stumpf, K Sonnenberg, É Szabó, P Pacher, ... Circulation research 90 (1), 100-106, 2002 | 202 | 2002 |
| Resistance to acute septic peritonitis in poly (ADP-ribose) polymerase-1-deficient mice FG Soriano, L Liaudet, E Szabo, L Virág, JG Mabley, P Pacher, C Szabo Shock 17 (4), 286-292, 2002 | 191 | 2002 |
| Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase JG Mabley, P Jagtap, M Perretti, SJ Getting, AL Salzman, L Virag, ... Inflammation Research 50, 561-569, 2001 | 174 | 2001 |
| Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury K Soejima, LD Traber, FC Schmalstieg, H Hawkins, JM Jodoin, C Szabo, ... American journal of respiratory and critical care medicine 163 (3), 745-752, 2001 | 155 | 2001 |
| Redox control of cancer cell destruction C Hegedűs, K Kovács, Z Polgár, Z Regdon, É Szabó, A Robaszkiewicz, ... Redox biology 16, 59-74, 2018 | 134 | 2018 |
| Dual role of poly (ADP-ribose) glycohydrolase in the regulation of cell death in oxidatively stressed A549 cells K Erdélyi, P Bai, I Kovács, É Szabó, G Mocsár, A Kakuk, C Szabó, ... The FASEB Journal 23 (10), 3553, 2009 | 131 | 2009 |
| Protective effect of a novel, potent inhibitor of poly (adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis RD Goldfarb, A Marton, É Szabó, L Virág, AL Salzman, D Glock, I Akhter, ... Critical care medicine 30 (5), 974-980, 2002 | 127 | 2002 |
| Detection of poly (ADP-ribose) polymerase activation in oxidatively stressed cells and tissues using biotinylated NAD substrate E Bakondi, P Bai, É Szabó, J Hunyadi, P Gergely, C Szabó, L Virág Journal of Histochemistry & Cytochemistry 50 (1), 91-98, 2002 | 113 | 2002 |
| Nitric oxide‐peroxynitrite‐poly (ADP‐ribose) polymerase pathway in the skin L Virág, É Szabó, E Bakondi, P Bai, P Gergely, J Hunyadi, C Szabó Experimental dermatology 11 (3), 189-202, 2002 | 104 | 2002 |
| Suppression of poly (ADP‐ribose) polymerase activation by 3‐aminobenzamide in a rat model of myocardial infarction: long‐term morphological and functional consequences L Liaudet, É Szabó, L Timashpolsky, L Virág, A Cziráki, C Szabó British journal of pharmacology 133 (8), 1424-1430, 2001 | 104 | 2001 |
| Peroxynitrite production, DNA breakage, and poly (ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity É Szabó, L Virág, E Bakondi, L Gyüre, G Haskó, P Bai, J Hunyadi, ... Journal of Investigative Dermatology 117 (1), 74-80, 2001 | 82 | 2001 |
| Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor R Faro, Y Toyoda, JD McCully, P Jagtap, E Szabo, L Virag, C Bianchi, ... The Annals of thoracic surgery 73 (2), 575-581, 2002 | 80 | 2002 |
| Partial protection by poly (ADP-ribose) polymerase inhibitors from nitroxyl-induced cytotoxity in thymocytes P Bai, E Bakondi, É Szabó, P Gergely, C Szabó, L Virág Free Radical Biology and Medicine 31 (12), 1616-1623, 2001 | 66 | 2001 |
| Role of intracellular calcium mobilization and cell-density-dependent signaling in oxidative-stress-induced cytotoxicity in HaCaT keratinocytes E Bakondi, M Gönczi, É Szabó, P Bai, P Pacher, P Gergely, L Kovács, ... Journal of investigative dermatology 121 (1), 88-95, 2003 | 57 | 2003 |
Laszlo ViragProfessor of Medical Chemistry, University of Debrecen, Faculty of Medicine, Hungary在 med.unideb.hu 的电子邮件经过验证
